UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 13, 2019
Colfax Corporation
(Exact name of registrant as specified in its charter)
Delaware | 001-34045 | 54-1887631 |
(State or other jurisdiction | (Commission | (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
420 National Business Parkway, 5th Floor
Annapolis Junction, MD 20701
(Address of Principal Executive Offices) (Zip Code)
(301) 323-9000
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On February 13, 2019, Colfax Corporation issued a press release reporting financial results for the fourth quarter ended December 31, 2018. A copy of Colfax Corporation's press release is attached to this report as Exhibit 99.1 and is incorporated in this report by reference. Colfax Corporation has scheduled a conference call for 8:30 a.m. Eastern on February 13, 2019 to discuss its financial results.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Colfax Corporation press release dated February 13, 2019, reporting financial results for the fourth quarter ended December 31, 2018.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: | February 13, 2019 | Colfax Corporation | ||
By: | /s/ Christopher M. Hix | |||
Name: | Christopher M. Hix | |||
Title: | Senior Vice President, Finance, | |||
Chief Financial Officer and Treasurer | ||||
EXHIBIT INDEX
Colfax Reports Fourth Quarter 2018 Results
• | Reported net income (loss) from continuing operations per diluted share of $0.36 versus $(1.53) in the prior year quarter; achieved adjusted net income per share of $0.69 versus $0.45 for 53% growth |
• | Sales increased 13% with 11% organic growth in both business platforms; strong year-over-year adjusted operating margin expansion |
• | Air & Gas Handling orders grew 12% including continued strong performance in Industrial applications |
• | Recently completed successful financing for DJO Global acquisition announced in November 2018; process to explore potential strategic options of Air & Gas Handling business well underway |
ANNAPOLIS JUNCTION, MD - February 13, 2019 - Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the fourth quarter of 2018.
The Company reported net income (loss) from continuing operations of $43 million or $0.36 per diluted share, compared to $(1.53) in the prior year quarter. Colfax also reported fourth quarter 2018 adjusted net income of $81 million or $0.69 per share compared to $0.45 per share for the same prior year period. Full year 2018 net income (loss) from continuing operations of $169 million, or $1.40 per diluted share, compared to $(0.59) in the prior year. Colfax also reported full year 2018 adjusted net income of $279 million, or $2.31 per share compared to $1.74 per share in the prior year.
Fourth quarter 2018 net sales of $985 million were 13% higher than the comparable period of 2017. Excluding acquisitions and foreign currency translation effects (FX), Fabrication Technology segment sales grew 11%, and Air & Gas Handling segment sales increased 11%. Fourth quarter 2018 Air & Gas Handling orders increased 12% to $412 million compared to the prior year period. Excluding acquisitions and FX, orders increased 13%.
Fourth quarter operating income was $49 million versus an operating loss of $(129) million in the prior year comparable quarter. Excluding goodwill and intangible asset impairment charges, and costs for restructuring and portfolio transformation, adjusted operating income was $92 million as compared with $69 million, and adjusted operating margins expanded 150 basis points to 9.4%. Air & Gas Handling adjusted operating margins grew 440 basis points to 12.1% as a result of restructuring actions, improved project margins and other business improvements. Fabrication Technology adjusted operating margins were 10.3% in the quarter or 11.2% excluding the October 2018 Gas Control Equipment acquisition. Fabrication Technology segment results included a property sale gain that was offset by other non-routine charges including Argentina hyper-inflation.
“Fourth quarter operating performance was in-line with expectations, and tax benefits contributed to outperformance,” said Matt Trerotola, Colfax President and CEO. “Fabrication Technology achieved strong sales growth from continued healthy market demand as well as new product launches, and pricing actions completed throughout the year. Air & Gas Handling drove another quarter of double-digit order growth with a significant mining project win and the successful long-term diversification into higher-growth end markets. We increased this business’ margins through restructuring actions and a deeper application of our business system to improve operational execution.”
In November 2018, Colfax announced the $3.15 billion acquisition of DJO Global as well as the launch of a project to explore strategic options for its Air & Gas Handling business. The DJO Global acquisition is expected to close in the first quarter of 2019 following receipt of regulatory approvals, and the Company recently completed the financing to support the acquisition and refinance existing bank loans. A process to explore the potential sale of the Air & Gas Handling business is well underway.
“Our acquisition of DJO is consistent with our strategy to create a higher margin, faster growing and less cyclical company,” said Mr. Trerotola. “DJO is a global leader in the attractive, growing orthopedic market, and we are excited about the potential to apply our business system to further improve the business’ growth and profitability. At the same time, we are improving the performance of our existing businesses and positioning our business portfolio to create sustained long-term value for our investors.”
Conference Call and Webcast
Colfax will host a conference call to provide details about its results today at 8:30 a.m. EST. The call will be open to the public by calling +1-877-303-7908 (U.S. callers) or +1-678-373-0875 (international callers) and referencing the conference ID number 5685539 or through webcast via Colfax’s website at www.colfaxcorp.com under the “Investors” section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.
About Colfax Corporation
Colfax Corporation is a leading diversified technology company that provides fabrication technology and air and gas handling products and services to customers around the world, principally under the ESAB and Howden brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. The Company uses its Colfax Business System (“CBS”), a comprehensive set of tools, processes and values, to create superior value for customers, shareholders and associates. Colfax is traded on the NYSE under the ticker “CFX.”
Non-GAAP Financial Measures and Other Adjustments
Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, organic sales growth, and organic order growth(decline). Adjusted operating income excludes Restructuring and other related items, Goodwill and intangible asset impairment charge and DJO acquisition-related costs. Adjusted net income and adjusted net income per share exclude Restructuring and other related charges, gain or loss on short term investments, Goodwill and intangible asset impairment charge, Pension settlement (gain) loss, acquisition-related intangibles amortization, and other non-cash acquisition related charges. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 16.8% and 18.2% for the fourth quarter and year ended December 31, 2018, respectively. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 20.1% and 25.7% for the fourth quarter and year ended December 31, 2017, respectively. Organic sales growth and organic order growth (decline) exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to discrete restructuring plans that are fundamentally different from the ongoing productivity improvements of the Company. Colfax management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax’s plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax’s results to differ materially from current expectations include, but are not limited to, factors detailed in Colfax’s reports filed with the U.S. Securities and Exchange Commission including its 2017 Annual Report on Form 10-K under the caption “Risk Factors.” In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.
The term “Colfax” in reference to the activities described in this press release may mean one or more of Colfax’s global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.
Contact:
Kevin Johnson, Vice President
Colfax Corporation
+1-301-323-9090
investorrelations@colfaxcorp.com
Colfax Corporation
Condensed Consolidated Statements of Income
Dollars in thousands, except per share data
(Unaudited)
Three Months Ended | Year Ended | ||||||||||||||
December 31, 2018 | December 31, 2017 | December 31, 2018 | December 31, 2017 | ||||||||||||
Net sales | $ | 985,226 | $ | 874,083 | $ | 3,666,812 | $ | 3,300,184 | |||||||
Cost of sales | 681,370 | 606,400 | 2,533,973 | 2,270,709 | |||||||||||
Gross profit | 303,856 | 267,683 | 1,132,839 | 1,029,475 | |||||||||||
Selling, general and administrative expense | 218,074 | 198,790 | 818,210 | 732,340 | |||||||||||
Restructuring and other related charges | 36,895 | 45,220 | 77,686 | 68,351 | |||||||||||
Goodwill and intangible asset impairment charge | — | 152,700 | — | 152,700 | |||||||||||
Operating income (loss) | 48,887 | (129,027 | ) | 236,943 | 76,084 | ||||||||||
Pension settlement (gain) loss | (39 | ) | 46,933 | (39 | ) | 46,933 | |||||||||
Interest expense, net | 14,899 | 12,031 | 44,052 | 41,137 | |||||||||||
Loss on short term investments | — | — | 10,128 | — | |||||||||||
Income (loss) from continuing operations before income taxes | 34,027 | (187,991 | ) | 182,802 | (11,986 | ) | |||||||||
(Benefit) provision for income taxes | (11,511 | ) | (3,574 | ) | (21 | ) | 42,554 | ||||||||
Net income (loss) from continuing operations | 45,538 | (184,417 | ) | 182,823 | (54,540 | ) | |||||||||
Income (loss) from discontinued operations, net of taxes | 2,912 | 202,257 | (28,350 | ) | 224,047 | ||||||||||
Net income | 48,450 | 17,840 | 154,473 | 169,507 | |||||||||||
Less: income attributable to noncontrolling interest, net of taxes | 2,556 | 4,550 | 14,277 | 18,417 | |||||||||||
Net income attributable to Colfax Corporation | 45,894 | 13,290 | 140,196 | 151,090 | |||||||||||
Net income (loss) per share - basic | |||||||||||||||
Continuing operations | $ | 0.37 | $ | (1.53 | ) | $ | 1.40 | $ | (0.59 | ) | |||||
Discontinued operations | $ | 0.02 | $ | 1.64 | $ | (0.24 | ) | $ | 1.82 | ||||||
Consolidated operations | $ | 0.39 | $ | 0.11 | $ | 1.16 | $ | 1.23 | |||||||
Net income (loss) per share - diluted | |||||||||||||||
Continuing operations | $ | 0.36 | $ | (1.53 | ) | $ | 1.40 | $ | (0.59 | ) | |||||
Discontinued operations | $ | 0.02 | $ | 1.63 | $ | (0.24 | ) | $ | 1.81 | ||||||
Consolidated operations | $ | 0.39 | * | $ | 0.10 | $ | 1.16 | $ | 1.22 | ||||||
* Net income per share amount does not add due to rounding.
Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Amounts in thousands, except per share data
(Unaudited)
Three Months Ended | Year Ended | ||||||||||||||
December 31, 2018 | December 31, 2017 | December 31, 2018 | December 31, 2017 | ||||||||||||
Adjusted Net Income and Adjusted Net Income Per Share | |||||||||||||||
Net income (loss) from continuing operations attributable to Colfax Corporation (1) | $ | 42,982 | $ | (188,967 | ) | $ | 168,546 | $ | (72,957 | ) | |||||
Restructuring and other related charges - pretax | 36,895 | 45,220 | 77,686 | 68,351 | |||||||||||
Goodwill and intangible asset impairment charge - pretax | — | 152,700 | — | 152,700 | |||||||||||
Pension settlement (gain) loss - pretax | (39 | ) | 46,933 | (39 | ) | 46,933 | |||||||||
Acquisition-related amortization and other non-cash charges - pretax(2) | 23,062 | 18,728 | 81,785 | 60,091 | |||||||||||
Portfolio transformation costs - pretax | 6,578 | — | 6,578 | — | |||||||||||
Loss on short term investments - pretax | — | — | 10,128 | — | |||||||||||
Tax adjustment (3) | (28,382 | ) | (18,779 | ) | (65,392 | ) | (38,789 | ) | |||||||
Adjusted net income from continuing operations | $ | 81,096 | $ | 55,835 | $ | 279,292 | $ | 216,329 | |||||||
Adjusted net income margin from continuing operations | 8.2 | % | 6.4 | % | 7.6 | % | 6.6 | % | |||||||
Weighted-average shares outstanding - diluted | 117,926 | 124,137 | 120,795 | 123,996 | |||||||||||
Adjusted net income per share continuing operations | $ | 0.69 | $ | 0.45 | $ | 2.31 | $ | 1.74 | |||||||
Net income (loss) per share- diluted from continuing operations (GAAP) | $ | 0.36 | $ | (1.53 | ) | $ | 1.40 | $ | (0.59 | ) | |||||
__________
(1) Net income from continuing operations attributable to Colfax Corporation for the respective periods is calculated using Net income from continuing operations less the income attributable to noncontrolling interest, net of taxes.
(2) Includes amortization of acquired intangibles and fair value charges on acquired inventory.
(3) The effective tax rates used to calculate adjusted net income and adjusted net income per share for the fourth quarter and year ended December 31, 2018 are 16.8% and 18.2%, respectively. These rates exclude the benefits of a $11.7 million deferred tax asset valuation allowance reversal and the $10.8m reduction in Transition Tax. The effective tax rates used to calculate adjusted net income and adjusted net income per share for the fourth quarter and year ended December 31, 2017 are 20.1% and 25.7%, respectively.
Colfax Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
Dollars in thousands
(Unaudited)
Three Months Ended | Year Ended | ||||||||||||||
December 31, 2018 | December 31, 2017 | December 31, 2018 | December 31, 2017 | ||||||||||||
Continuing Operations | |||||||||||||||
Operating income (loss) | $ | 48,887 | $ | (129,027 | ) | $ | 236,943 | $ | 76,084 | ||||||
Operating income (loss) margin | 5.0 | % | (14.8 | )% | 6.5 | % | 2.3 | % | |||||||
Restructuring and other related charges | 36,895 | 45,220 | 77,686 | 68,351 | |||||||||||
Goodwill and intangible asset impairment charge | — | 152,700 | — | 152,700 | |||||||||||
Portfolio transformation costs | 6,578 | — | 6,578 | — | |||||||||||
Adjusted operating income | $ | 92,360 | $ | 68,893 | $ | 321,207 | $ | 297,135 | |||||||
Adjusted operating income margin | 9.4 | % | 7.9 | % | 8.8 | % | 9.0 | % | |||||||
Colfax Corporation
Change in Sales, Orders and Backlog
Dollars in millions
(Unaudited)
Air and Gas Handling | |||||||||||||
Net Sales | Orders | ||||||||||||
$ | % | $ | % | ||||||||||
For the three months ended December 31, 2017 | $ | 874.1 | $ | 368.5 | |||||||||
Components of Change: | |||||||||||||
Existing businesses(1) | 92.8 | 10.6 | % | 48.6 | 13.2 | % | |||||||
Acquisitions(2) | 60.5 | 6.9 | % | 6.2 | 1.7 | % | |||||||
Foreign currency translation | (42.2 | ) | (4.8 | )% | (11.5 | ) | (3.1 | )% | |||||
111.1 | 12.7 | % | 43.3 | 11.8 | % | ||||||||
For the three months ended December 31, 2018 | $ | 985.2 | $ | 411.8 | |||||||||
Air and Gas Handling | ||||||||||||||||||||
Net Sales | Orders | Backlog at Period End | ||||||||||||||||||
$ | % | $ | % | $ | % | |||||||||||||||
As of and for the year ended December 31, 2017 | $ | 3,300.2 | $ | 1,306.5 | $ | 893.4 | ||||||||||||||
Components of Change: | ||||||||||||||||||||
Existing businesses(1) | 127.5 | 3.9 | % | (30.3 | ) | (2.3 | )% | (49.4 | ) | (5.5 | )% | |||||||||
Acquisitions(2) | 260.8 | 7.9 | % | 136.9 | 10.5 | % | 30.8 | 3.4 | % | |||||||||||
Foreign currency translation | (21.7 | ) | (0.7 | )% | 23.3 | 1.7 | % | (42.6 | ) | (4.8 | )% | |||||||||
366.6 | 11.1 | % | 129.9 | 9.9 | % | (61.2 | ) | (6.9 | )% | |||||||||||
As of and for the year ended December 31, 2018 | $ | 3,666.8 | $ | 1,436.4 | $ | 832.2 | ||||||||||||||
__________
(1) Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price, product mix and volume.
(2) Represents the incremental sales, orders and order backlog from the acquisition completed in our Air and Gas Handling segment, and incremental sales for acquisitions completed in our Fabrication Technology segment.
Colfax Corporation
Condensed Consolidated Balance Sheets
Dollars in thousands, except share amounts
(Unaudited)
December 31, 2018 | December 31, 2017 | ||||||
ASSETS | |||||||
CURRENT ASSETS: | |||||||
Cash and cash equivalents | $ | 245,019 | $ | 262,019 | |||
Short term investments | — | 149,608 | |||||
Trade receivables, less allowance for doubtful accounts of $35,152 and $31,488 | 989,418 | 970,199 | |||||
Inventories, net | 496,535 | 429,627 | |||||
Other current assets | 227,469 | 258,379 | |||||
Total current assets | 1,958,441 | 2,069,832 | |||||
Property, plant and equipment, net | 503,344 | 552,802 | |||||
Goodwill | 2,576,617 | 2,538,544 | |||||
Intangible assets, net | 1,012,913 | 1,017,203 | |||||
Other assets | 552,557 | 531,316 | |||||
Total assets | $ | 6,603,872 | $ | 6,709,697 | |||
LIABILITIES AND EQUITY | |||||||
CURRENT LIABILITIES: | |||||||
Current portion of long-term debt | $ | 6,334 | $ | 5,766 | |||
Accounts payable | 640,667 | 587,129 | |||||
Customer advances and billings in excess of costs incurred | 147,307 | 145,853 | |||||
Accrued liabilities | 405,037 | 358,632 | |||||
Total current liabilities | 1,199,345 | 1,097,380 | |||||
Long-term debt, less current portion | 1,192,408 | 1,055,305 | |||||
Other liabilities | 735,173 | 829,748 | |||||
Total liabilities | 3,126,926 | 2,982,433 | |||||
Equity: | |||||||
Common stock, $0.001 par value; 400,000,000 shares authorized; 117,275,217 and 123,245,827 issued and outstanding | 117 | 123 | |||||
Additional paid-in capital | 3,057,982 | 3,228,174 | |||||
Retained earnings | 991,838 | 846,490 | |||||
Accumulated other comprehensive loss | (780,177 | ) | (574,372 | ) | |||
Total Colfax Corporation equity | 3,269,760 | 3,500,415 | |||||
Noncontrolling interest | 207,186 | 226,849 | |||||
Total equity | 3,476,946 | 3,727,264 | |||||
Total liabilities and equity | $ | 6,603,872 | $ | 6,709,697 | |||
Colfax Corporation
Condensed Consolidated Statements of Cash Flows
Dollars in thousands
(Unaudited)
Year Ended | |||||||
December 31, 2018 | December 31, 2017 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 154,473 | $ | 169,507 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Impairment of goodwill, intangibles and property, plant and equipment | 7,086 | 183,751 | |||||
Depreciation and amortization | 141,877 | 132,203 | |||||
Stock-based compensation expense | 25,103 | 21,548 | |||||
Non-cash interest expense | 4,415 | 4,519 | |||||
Loss on short term investments | 10,128 | — | |||||
Deferred income tax (benefit) expense | (66,573 | ) | 12,066 | ||||
Gain on sale of property, plant and equipment | (21,108 | ) | (11,243 | ) | |||
Loss (Gain) on Sale of Business | 4,337 | (308,388 | ) | ||||
Pension settlement (gain) loss | (39 | ) | 46,933 | ||||
Changes in operating assets and liabilities: | |||||||
Trade receivables, net | (72,405 | ) | (44,345 | ) | |||
Inventories, net | (47,156 | ) | (34,023 | ) | |||
Accounts payable | 70,085 | 10,266 | |||||
Customer advances and billings in excess of costs incurred | 18,481 | (24,388 | ) | ||||
Changes in other operating assets and liabilities | (2,337 | ) | 60,364 | ||||
Net cash provided by operating activities | 226,367 | 218,770 | |||||
Cash flows from investing activities: | |||||||
Purchases of property, plant and equipment | (69,646 | ) | (68,765 | ) | |||
Proceeds from sale of property, plant and equipment | 34,829 | 21,224 | |||||
Acquisitions, net of cash received | (290,918 | ) | (346,764 | ) | |||
Proceeds from sale of business, net | 18,404 | 490,308 | |||||
Sale of short term investments, net | 139,480 | — | |||||
Other, net | — | (6,127 | ) | ||||
Net cash (used in) provided by investing activities | (167,851 | ) | 89,876 | ||||
Cash flows from financing activities: | |||||||
Payments under term credit facility | (131,250 | ) | (65,628 | ) | |||
Proceeds from borrowings on revolving credit facilities and other | 1,271,051 | 1,046,457 | |||||
Repayments of borrowings on revolving credit facilities and other | (981,563 | ) | (1,632,658 | ) | |||
Proceeds from borrowings on senior unsecured notes | — | 374,450 | |||||
Proceeds from issuance of common stock, net | 4,699 | 6,944 | |||||
Common stock repurchases | (200,000 | ) | — | ||||
Other | (10,090 | ) | (10,012 | ) | |||
Net cash used in financing activities | (47,153 | ) | (280,447 | ) | |||
Effect of foreign exchange rates on Cash and cash equivalents | (28,363 | ) | 12,090 | ||||
(Decrease) increase in Cash and cash equivalents | (17,000 | ) | 40,289 | ||||
Cash and cash equivalents, beginning of period | 262,019 | 221,730 | |||||
Cash and cash equivalents, end of period | $ | 245,019 | $ | 262,019 | |||
Supplemental Disclosure of Cash Flow Information: | |||||||
Non-cash consideration received from sale of business | $ | — | $ | 206,415 | |||
Interest payments | 50,389 | 43,496 | |||||
Income tax payments, net | 97,452 | 70,668 | |||||